Overexpression of Spondin-2 Is Associated with Recurrence-Free Survival in Patients with Localized Clear Cell Renal Cell Carcinoma

Figure 4

The correlation of SPON2 mRNA expression with prognosis. (a) SPON2 mRNA expression in patients with metastatic and localized ccRCC from GSE47352. (b) Kaplan-Meier overall survival analysis in patients from TCGA ccRCC dataset. (c) SPON2 mRNA expression in localized ccRCC patients with and without recurrence. (d) ROC analysis of SPON2 mRNA expression in localized ccRCC patients. (e) Kaplan-Meier recurrence-free survival analysis in localized ccRCC patients.

(a)

(b)

(c)

(d)

(e)